Arendt J., Wirtz-Justice A., Bradtke J., Komeg-Mark M. Long-term studies on immunoreactive human melatonin. Ann. Clin. Biochem. 16:1979;307-312.
Arendt J., Bojkowski C., Franey C., Wright J., Marks V. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J. Clin. Endocrinol. Metab. 60:1985;1166-1173.
Bartsch C., Bartsch H., Schmidt A., Ilg S., Bichler K.H., Fluchter S.H. Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations. Clin. Chim. Acta. 209:1992;153-167.
Beck-Friis J., Kjellman B.F., Aperia B., Unden F., von Rosen D., Ljunggren J.G., Wetterberg L. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr. Scand. 71:1985;319-330.
Bojkowski C.J., Arendt J. Factors influencing urinary 6-sulfatoxymelatonin, a major melatonin metabolite, in normal human subjects. Clin. Endocrinol. 33:1990;435-444.
Bojkowski C.J., Arendt J., Shih M.C., Markey S.P. Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin. Clin. Chem. 33:1987;1343-1348.
Branchey L., Weinberg U., Branchey M., Linkowski P., Mendlewicz J. Simultaneous study of 24 hours patterns of melatonin and cortisol secretion in depressed patients. Neuropsychobiology. 8:1982;225-232.
Brown R. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am. J. Psychiat. 142:1985;811-816.
Brown R.P., Kocsis J.H., Caroff S., Amsterdam J., Winokur A., Stokes P., Frazer A. Melatonin in depressed patients. Acta Psychiat. Scand. 76:1987;272-275.
Checkley S.A., Park S.B.G. The psychopharmacology of the human pineal. J. Psychopharmac. 2:1987;109-125.
Claustrat B., Brun J., Chazot G. Melatonin in humans, neuroendocrinological and pharmacological aspects. Nucl. Med. Biol. 17:1990;625-632.
Claustrat B., Chazot G., Brun J., Jordan D., Sassolas G. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol. Psychiat. 19:1984;1215-1228.
Crasson M., Beckers V., Pequeux Ch., Claustrat B., Legros J.J. Daytime 50-Hz magnetic field exposure and plasma melatonin and urinary 6-sulfatoxymelatonin concentration profiles in humans. J. Pineal Res. 31:2001;234-241.
Cook M.R., Graham C., Kavet R., Stevens R.G., Davis S., Kheifets L. Morning urinary assessment of nocturnal melatonin secretion in older women. J. Pineal Res. 28:2000;41-47.
Copinschi G., Van Onderbergen A., L'Hermite-Balériaux M., Szyper M., Caufriez A., Bosson D., L'Hermite M., Robyn C., Turek F.W., Van Cauter E. Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Sleep. 13:1990;232-244.
Fanget F., Terra J.L., Dalery J., Brun J., Claustrat B., Marie-Cardine M., Guyotat J. Rythme circannuel de mélatonine chez des patients maniaco-dépressif. Encéphale. 16:1990;197-202.
Frazer A., Brown R., Kocsis J., Caroff S., Amsterdam J., Winokur A., Sweeney J., Stokes P. Patterns of melatonin rhythms in depression. J. Neural Transm. 21:1986;269-290.
Gibertini M., Graham Ch., Cook M.R. Self-report of circadian type reflects the phase of the melatonin rhythm. Biol. Psychol. 50:1999;19-33.
Graham C., Cook M.R., Kavet R., Sastre A., Smith D.K. Prediction of nocturnal plasma melatonin from morning urinary measures. J. Pineal Res. 24:1998;230-238.
Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiat. 23:1960;56-62.
Hanssen T., Heyden T., Sunderg I., Wetterberg L. Effet of propanolol on serum melatonin. Lancet. 2:1977;309-310.
Harthe C., Claustrat B., Brun J., Chazot G. Direct radioimmunoassay of 6-sulfatoxymelatonin in plasma with use of an iodinated tracer. Clin. Chem. 37:1991;536-539.
Hartter S., Wang X., Weigman H., Friedberg T., Arand M., Oesch F., Hiemke C. Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. J. Clin. Psychopharmac. 21:2001;167-174.
Hendrick J.C., Crasson M., Hagelstein M.T., Bruls E., Legros J.J. Approche statistique de 1'influence de l'âge et du sexe sur l'excrétion de 6-sulfatoxymélatonine urinaire (a-MT6s) chez l'individu normal. Ann. Endocrinol. 63:2002;3-7.
Kabuto M., Namura I., Saitoh Y. Nocturnal enhancement of plasma melatonin could be suppressed by benzodiazepines in humans. Endocrinol. Jap. 33:1986;405-414.
Kennedy S.H., Garfinkel P.E., Parienti V., Costa D., Brown G.M. Changes in melatonin levels but not cortisol levels are associated with depression in patients with eating disorders. Arch. Gen. Psychiatry. 46:1989;73-78.
Klante G., Brinschwitz T., Secci K., Wollnik F., Steinlechner S. Creatinine is an appropriate reference for urinary sulphatoxymelatonin of laboratory animals and humans. J. Pineal Res. 23:1997;191-197.
Lewy A.J. Effects of light on human melatonin production and the human circadian system. Prog. Neuropsychopharmac. Biol. Psychiat. 7:1983;551-556.
Markey S.P., Higa S., Shih M., Danforth D.N., Tamarkin L. The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion. Clin. Chim. Acta. 150:1985;221-225.
Mendlewicz J., Linkowski P., Branchey L. Abnormal 24 hours pattern of melatonin secretion in depression. Lancet. 2:1979;1362.
Miles A., Philbrick D.R. Melatonin and psychiatry. Biol. Psychiat. 23:1988;405-425.
Moore D.C., Paunier Sizonenko L. Effect of adrenergic stimulation and blockade on melatonin secretion in the human. Ariens Kappers J., Pevet P. The Pineal Gland of Vertebrates including Man. 1979;517-521 Elsevier/North Holland, Biomedical Press, Amsterdam.
Nair N.P., Hariharasubramanian N., Pilapil C. Circadian rhythm of plasma in endogenous depression. Prog Neuropsychopharmac. Biol. Psychiat. 8:1984;715-718.
Norman T.R., Piccolo J., Voudouris N., Burrows G.D. The effect of single oral doses of zopiclone on nocturnal melatonin secretion in healthy male volunteers. Prog. Neuropsychopharmac. Biol. Psychiat. 25:2001;825-833.
Nowak R., Mcmillen C., Redman J., Short R.V. The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: two non-invasive techniques for monitoring human circadian rhythmicity. Clin. Endocrinol. 27:1987;445-452.
Pacchierotti C., Iapichino S., Bossini L., Pieraccini F., Castrogiovanni P. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol. 22:2001;18-32.
Rubin R.T., Heist K., Mcgeoy S.S., Hanada K., Lesser I.M. Neuroendocrine aspects of primary endogenous depression: XI. Serum melatonin measures in patients and matched control subjects. Arch. Gen. Psychiat. 49:1992;558-567.
Sekula L.K., Lucke J.F., Heist E.K., Czambel R.K., Rubin R.T. Neuroendocrine aspects of primary endogenous depression XV: mathematical modeling of nocturnal melatonin secretion in major depressives and normal controls. Psychiat. Res. 69:1997;143-153.
Souetre E., Salvati E., Belugou J.L., Pringuey D., Candito M., Krebs B., Ardisson J.L., Darcourt G. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiat. Res. 28:1989;263-278.
Stewart J.W., Halbreich U. Plasma melatonin levels in depressed patients before and after treatment with antidepressant medication. Biol. Psychiat. 25:1989;33-38.
Thompson C., Franey C., Arendt J., Checkley S.A. Comparison of melatonin secretion in normal subjects and depressed patients. Br. J. Psychiat. 152:1988;260-266.
Van Cauter E., Sturis J., Byrne M.M., Blackman J.D., Leproult R., Ofek G., L'Hermite-Baleriaux M., Refetoff S., Turek F.W., Van Reeth O. Demonstration of rapid light-induced advances and delays of the human circadian clock using hormonal phase markers. Am. J. Physiol. 266:1994;E953-E963.
von Bahr C., Ursing C., Tybring G., Bertilsson L., Rojdmark S. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects - an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. Eur. J. Clin. Pharmac. 56:2000;123-127.
Wetterberg L., Beck-Friis J., Aperia B., Petterson H. Melatonin/cortisol ratio in depression. Lancet. 2:1979;1361.
Zetin M., Potkin S., Urbanchek M. Melatonin in depresion. Psychiat. Ann. 17:1987;676-681.
